Quarterly report pursuant to Section 13 or 15(d)

Revenue Information

v3.20.1
Revenue Information
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Revenue Information

Note 9 – Revenue Information

 

Revenue by product lines was as follows:

 

    Three Months Ended  
    March 31,  
Product Line   2020     2019  
MicroParticle Catalyzed Biosensor (“MPC”)   $ -     $ 23,320  
Particle ImmunoFiltration Assay (“PIFA”)     354,458       576,317  
Other     9,057       12,486  
Total Revenue   $ 363,515     $ 612,123  

 

All revenues for the three months ended March 31, 2020 and 2019 were generated through sales to customers who were located within the United States.

 

The Company had long-lived assets totaling $8,518 and $9,823 located in the People’s Republic of China and $176,757 and $194,174 located in the United States as of March 31, 2020 and December 31, 2019, respectively.